BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 2986176)

  • 1. Procoagulant activity of human neuroblastoma cell lines, in relation to cell growth, differentiation and cytogenetic abnormalities.
    Esumi N; Imashuku S; Tsunamoto K; Todo S; Misawa S; Goto T; Fujisawa Y
    Jpn J Cancer Res; 1989 May; 80(5):438-43. PubMed ID: 2502520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanism of human neuroblastoma cell adhesion to fibronectin.
    Yoshihara T; Ikushima S; Shimizu Y; Esumi N; Todo S; Humphries MJ; Imashuku S
    Clin Exp Metastasis; 1991; 9(4):363-75. PubMed ID: 1831074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma].
    Imashuku S; Esumi N; Todo S; Nakajima F
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):775-80. PubMed ID: 6585182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-aortic prostaglandin E1 infusion in maturation of neuroblastoma.
    Imashuku S; Sugano T; Fujiwara K; Todo S; Ogita S; Goto Y
    Experientia; 1982 Aug; 38(8):932-3. PubMed ID: 6889979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intra-aortic prostaglandin E1 infusion in the treatment of advanced neuroblastoma].
    Imashuku S; Todo S; Nakajima F
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1936-43. PubMed ID: 6311112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression and differentiation of neuroblastoma tumors in mice treated with differentiating agents--prostaglandin E1 and a phosphodiesterase inhibitor, RO 20-1724.
    Anderson DW; Crowle AJ
    Cancer Lett; 1982 Sep; 16(3):287-95. PubMed ID: 6891284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma.
    Imashuku S; Todo S; Esumi N; Hashida T; Tsunamoto K; Nakajima F
    Prog Clin Biol Res; 1985; 175():89-98. PubMed ID: 2986176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cell growth inhibition by prostaglandins and its action mechanism].
    Narumiya S; Kato T; Fukushima M
    Seikagaku; 1985 Jul; 57(7):578-93. PubMed ID: 3906000
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological activities of 6-keto-prostaglandin E1.
    Lewis R; Schölkens BA; Beck G
    Prostaglandins Leukot Med; 1984 Dec; 16(3):303-24. PubMed ID: 6098901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action and metabolism of prostaglandins in the pulmonary circulation.
    Kadowitz PJ; Lippton HL; McNamara DB; Spannhake EW; Hyman AL
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():333-56. PubMed ID: 6216787
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of action of vitamin E on mammalian tumor cells in culture.
    Prasad KN
    Prog Clin Biol Res; 1988; 259():363-75. PubMed ID: 2834742
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.